Blog
Can Shopify Balance Sidekick Growth With Higher LLM Costs?
Shopify Inc. SHOP is deepening its artificial intelligence strategy, with Sidekick emerging as a key merchant-facing tool within its broader platform. While AI-led discovery remains an important
Will MasTec's Turnkey Strategy Unlock More Data Center Deals?
MasTec, Inc. MTZ is increasingly positioning itself as a one-stop infrastructure partner for hyperscale and enterprise customers, raising an important question for investors: Can its turnkey
Google: AI Skeptics Proven Wrong as Business Booms
Alphabet Company Overview
Zacks Rank #3 (Hold) company Alphabet (GOOGL) is the web search king and one of the most innovative tech companies in the world. Over the past few years, the company has
Top 3 Streaming Stocks to Watch as Monetization Gains Momentum
An updated edition of the April 13, 2026 article.Streaming content is entering a more mature phase as the industry shifts from rapid subscriber acquisition to steadier monetization. Platforms are no
Amgen Secures EU Nod for Imdylltra in Lung Cancer Indication
Amgen AMGN announced that the European Commission (“EC”) has approved Imdylltra (tarlatamab) to treat adults with extensive-stage small cell lung cancer (“SCLC”) who require systemic therapy
Comfort Systems' Tech Boom: Growth Engine or Concentration Risk?
Comfort Systems USA, Inc. FIX is riding one of the strongest growth waves in its history, but its increasing reliance on technology customers raises an important question: could concentration risk
Edgewise Therapeutics Stock Hits Record High on $2.65B Servier Deal
Shares of Edgewise Therapeutics EWTX jumped 17.9% on Monday, closing at an all-time high after the company announced a transformative agreement to sell its lead muscular dystrophy asset, sevasemten
4 Gaming Stocks Worth Watching Despite Industry Headwinds
RTX Outperforms Industry in the Past 6 Months: Should You Buy?
RTX Corporation RTX stock has surged 3.9% in the past six months, outperforming the Zacks Aerospace-Defense industry’s decline of 3.1%. However, it underperformed the broader Zacks Aerospace
HIVE Digital Technologies (HIVE) Reports Q4 Loss, Misses Revenue Estimates
HIVE Digital Technologies (HIVE) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to a loss of $0.31 per share a year ago
FDA Accepts Vertex's BLA for Povetacicept in IgA Nephropathy
Vertex Pharmaceuticals VRTX announced that the FDA has accepted its biologics license application (BLA) seeking approval for its investigational candidate, povetacicept, for treating adults with
Sterling and Data Centers: The Integrated Buildout Trade
Sterling Infrastructure, Inc. STRL has become a direct way to play the next leg of mission-critical construction. Management is leaning into structurally expanding end markets, with demand tied to
3 Storage Devices Stocks to Buy as the Industry Gains Momentum
FDA Grants Priority Review to Roche's Early-Stage Breast Cancer NDA
Roche RHHBY announced that the FDA has accepted its new drug application (NDA) for its investigational candidate, giredestrant, as an adjuvant treatment for adults with oestrogen receptor
CoreWeave Last Year, Now SpaceX: Decade Defining IPOs?
IPO activity post-pandemic saw a big downturn for several years, primarily driven by economic uncertainty, shifting monetary policy, and inflation, all of which impacted investor sentiment.
But the
MRNA Partners With CEPI to Develop Vaccine for Bundibugyo Ebolavirus
Moderna MRNA announced a new collaboration with the Coalition for Epidemic Preparedness Innovations (“CEPI”) to accelerate the development of a potential vaccine targeting Bundibugyo ebolavirus
Can ISRG's Digital Roadmap Unlock the Next Phase of Robotic Surgery?
Intuitive Surgical’s ISRG next growth frontier may not be a new robotic platform but the digital ecosystem being built around its installed base. During the first quarter of 2026, management
Dollar General Beats Q1 Earnings Estimates, Raises FY26 View
Dollar General Corporation DG reported first-quarter fiscal 2026 results, wherein the top line missed the Zacks Consensus Estimate, while the bottom line beat the same. Both net sales and earnings
Should You Buy Sterling Stock After Its 176% YTD Surge?
Sterling Infrastructure, Inc. STRL is up 176.1% year to date, a move that dwarfs the Zacks sub-industry’s 37.9% growth, the Zacks Construction sector’s 12.2% rise and the S&P 500’s 11.1% advance
TNDM Stock: What to Know About Tandem's 2026 Reset
Tandem Diabetes Care TNDM is pushing two levers at once in 2026: improving operating performance while shifting more U.S. business toward a pharmacy-based, pay-as-you-go pathway. That mix can make
How ALTO Is Benefiting From Stronger Essential Ingredients Returns
Alto Ingredients, Inc. ALTO generates value from more than just alcohol production. Its business model is built around maximizing returns from every bushel of corn, with essential ingredients
STRL's Backlog Visibility: What It Means for 2026-2027 Growth
Sterling Infrastructure, Inc. STRL is in a cycle where visibility matters as much as velocity. The company is converting mission-critical demand into a deeper backlog, while expanding scope through





